Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NGM Biopharmaceuticals Inc (NGM)
NASDAQ:NGM
Holding NGM?
Track your performance easily
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 582.00K | $ 1.42M | $ 2.20M | $ 18.15M | $ 7.91M |
| Gross Profit | $ 582.00K | $ 1.42M | $ 2.20M | $ 18.15M | - |
| EBIT | $ -28.80M | $ -38.26M | $ -47.69M | $ -38.50M | $ -48.30M |
| EBITDA | $ -29.15M | $ -38.70M | $ -48.11M | $ -38.25M | $ -47.71M |
| Net Income Common Stockholders | $ -28.80M | $ -38.26M | $ -47.69M | $ -36.47M | $ -47.26M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 166.04M | $ 195.04M | $ 232.50M | $ 271.49M | $ 300.15M |
| Total Assets | $ 192.15M | $ 219.81M | $ 258.84M | $ 307.40M | $ 335.87M |
| Total Debt | $ 1.38M | $ 2.75M | $ 4.07M | $ 5.38M | $ 6.69M |
| Net Debt | $ -164.66M | $ -192.29M | $ -228.43M | $ -266.11M | $ -293.46M |
| Total Liabilities | $ 22.34M | $ 28.42M | $ 37.90M | $ 307.44M | $ 49.98M |
| Stockholders Equity | $ 169.81M | $ 192.12M | $ 220.93M | $ 259.59M | $ 285.89M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -27.49M | $ -40.32M | $ -42.50M | $ -30.86M | $ -28.46M |
| Operating Cash Flow | $ -27.20M | $ -40.22M | $ -41.83M | $ -30.42M | $ -28.15M |
| Investing Cash Flow | $ 26.87M | $ 24.59M | $ 35.64M | $ 1.69M | $ 35.45M |
| Financing Cash Flow | - | $ 1.39M | $ 279.00K | $ 723.00K | $ 33.22M |